PeakspanSociety

The writing

Field Guides

Practical, evidence-aware deep dives across the five pillars. Educational, not medical advice.

Recover

Cold Water and the Breath: What Wim Hof Got Right, and What Can Kill You

Cold plunges and Wim Hof breathing are sold as one miracle practice. The recovery evidence is real, the general-health hype is thin, and the breathing technique has killed people when mixed with water. Here's the honest version — and two protocols kept deliberately apart.

The Peakspan Desk · Jul 29, 2026 · 9 min read

Frontier

KPV: The Three-Amino-Acid Anti-Inflammatory With a Replication Problem It Doesn't Have

Most Frontier peptides rest on one lab's work. KPV is different — two independent groups, decades of consistent anti-inflammatory data, a clean mechanism. And still zero completed human trials. Here's what that combination means.

The Peakspan Desk · Jul 27, 2026 · 8 min read

Frontier

MOTS-c: The Exercise You Can't Inject

MOTS-c is a peptide your own mitochondria make when you exercise. That's what makes it scientifically fascinating — and exactly why 'exercise in a vial' is the wrong way to think about it. What the mitochondrial-derived peptide research actually shows.

The Peakspan Desk · Jul 27, 2026 · 8 min read

Frontier

TB-500: The Human Trials Belong to a Different Molecule

TB-500 is marketed on the strength of thymosin beta-4 research — including real human trials. But TB-500 isn't thymosin beta-4. It's a fragment, and the fragment barely appears in human data at all. The bait-and-switch is the story.

The Peakspan Desk · Jul 27, 2026 · 8 min read

Move

Balance

Falls kill more adults over 65 than car accidents. A 10-second test predicts your risk. A few minutes a day changes it.

The Peakspan Desk · Jul 21, 2026 · 8 min read

Recover

Meditation After the Hype

Meditation survived its hype cycle with real, moderate evidence for anxiety and depression — comparable to medication for mild symptoms. What the data supports, and a simple 8-week dose.

The Peakspan Desk · Jul 21, 2026 · 6 min read

Explore

The Purpose Effect

Purpose isn't soft advice. A JAMA study of nearly 7,000 adults found a strong sense of purpose was significantly associated with lower mortality. In Okinawa, they have a word for it.

The Peakspan Desk · Jul 21, 2026 · 7 min read

Measure

VO2 Max

A study of 122,007 adults found the gap between the least and most fit was larger than the difference between smokers and non-smokers. VO2 max is the most powerful predictor of longevity we have — and it's trainable.

The Peakspan Desk · Jul 21, 2026 · 7 min read

Frontier

The Rapamycin Paradox: When the Best Longevity Drug Works Against the Best Longevity Practice

The first human trial pairing rapamycin with exercise found the drug blunted the gains. For anyone who actually moves their body, this is the most important result in longevity science this year.

The Peakspan Desk · Jul 18, 2026 · 8 min read

Frontier

The FDA Peptide Hearing: 7 Compounds, One Question

BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, and Epitalon went before the FDA on July 23-24, 2026. Here's what each one claims to do, what the evidence actually shows, and what the committee decided.

The Peakspan Desk · Jul 17, 2026 · 10 min read

Frontier

BPC-157: The Healing Peptide With No Human Proof

100+ animal studies. Two human participants. Zero controlled trials. The most popular peptide in the longevity underground went before the FDA in July 2026 — which recommended it for compounding despite its own staff's objections. Here's what the evidence actually says.

The Peakspan Desk · Jul 16, 2026 · 8 min read

Frontier

The GLP-1 Longevity Paradox: The Drug That Might Slow Your Aging While Stealing Your Strength

Semaglutide may slow biological aging by 9%. It also strips up to 40% of weight loss from muscle. For the over-40 crowd chasing healthspan, this trade-off is the most important question in medicine right now.

The Peakspan Desk · Jul 16, 2026 · 9 min read

Explore

Go Look at Something Big: Awe as a Longevity Practice

The most underrated intervention for a long life isn't in a bottle. It's the feeling you get standing at the top of a climb, small against something vast.

The Peakspan Desk · Jun 30, 2026 · 6 min read

Move

Strength Training After 50: The Minimum Effective Dose

You don't need a bodybuilder's schedule. You need tension, progression, and consistency — here's the smallest dose that works.

The Peakspan Desk · Jun 28, 2026 · 7 min read

Eat

The Longevity Kitchen

The supplement aisle is a $228 billion stage. Four things in your kitchen do most of the work it's selling — and photograph terribly. Here's the honest version.

The Peakspan Desk · Jun 25, 2026 · 8 min read

Move

The Zone 2 Base: Building an Aerobic Engine That Lasts Decades

The slowest training you'll ever do is the foundation of a long, capable life. Here's how to know you're actually in the zone.

The Peakspan Desk · Jun 22, 2026 · 7 min read

Recover

Train the Mind Like a Muscle

A sharp mind at 80 isn't luck. The 2020 Lancet Commission found roughly 40% of dementia cases are linked to modifiable risk factors. Here's where to spend your attention.

The Peakspan Desk · Jun 20, 2026 · 7 min read

Eat

Protein, Muscle, and the Long Game After 40

Muscle preserves independence, glucose handling, and physical capacity with age. Here's how much protein it takes to keep yours — and why the supplement shelf is shorter than you think.

The Peakspan Desk · Jun 18, 2026 · 7 min read

Recover

Sleep Is the Original Longevity Drug

No supplement stack outperforms a consistent night of deep sleep. The levers that actually move it — ranked by cost and payoff.

The Peakspan Desk · Jun 12, 2026 · 6 min read

Measure

Do Healthy People Need a Continuous Glucose Monitor?

Now that CGMs are over-the-counter, should the metabolically healthy bother? A real cost-benefit — and how to run a useful two-week experiment.

The Peakspan Desk · Jun 6, 2026 · 7 min read